Zyflamend (Herbal Blend)

Zyflamend is a proprietary herbal blend containing ten anti-inflammatory botanicals—including turmeric, rosemary, ginger, and holy basil—that collectively inhibit COX-2, LOX, and NF-κB signaling pathways. Its multi-target mechanism makes it a studied candidate for inflammation modulation and prostate health support.

Origin & History

Zyflamend is a proprietary polyherbal blend consisting of 10 herbal extracts developed by New Chapter, combining turmeric, ginger, rosemary, holy basil, green tea, hu zhang, Chinese goldthread, barberry, oregano, and Chinese skullcap. The individual herbs are extracted using supercritical extraction, hydroethanolic extraction, and aqueous extraction methods to preserve different bioactive compounds.

Historical & Cultural Context

The individual herbs in Zyflamend have extensive traditional medicine histories, with turmeric and ginger being foundational in Ayurvedic and Traditional Chinese Medicine, holy basil central to Ayurvedic practice, and Chinese goldthread, barberry, hu zhang, and skullcap used in Traditional Chinese Medicine. Rosemary, oregano, and green tea have been used in Mediterranean and Asian traditional medicine practices for centuries.

Health Benefits

• May support prostate health by helping lower PSA levels (limited human evidence)
• Exhibits anti-inflammatory properties at physiologically relevant doses (preclinical evidence)
• Demonstrates anti-tumorigenic properties in laboratory settings (in-vitro evidence)
• Activates AMPK, a key metabolic regulator (animal model evidence)
• May modulate estrogen-producing enzymes and induce cancer cell death (laboratory evidence only)

How It Works

Zyflamend suppresses inflammatory signaling primarily by inhibiting cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) enzymes, reducing prostaglandin and leukotriene synthesis. Its constituent compounds—including curcumin from turmeric, ursolic acid from rosemary, and [6]-gingerol from ginger—collectively block NF-κB nuclear translocation, dampening pro-inflammatory cytokine transcription. Additionally, Zyflamend activates AMP-activated protein kinase (AMPK), a master metabolic regulator that further suppresses mTOR-driven inflammatory and proliferative signaling.

Scientific Research

Human clinical evidence for Zyflamend is limited, with only a small study suggesting potential benefits for prostate health through PSA reduction. Most research has been conducted in laboratory and preclinical settings rather than human trials, with Memorial Sloan Kettering Cancer Center noting that 'studies in humans are quite limited.' No specific PMIDs were provided in the research dossier.

Clinical Summary

A pilot phase II trial in 23 men with high-grade prostatic intraepithelial neoplasia (HGPIN) found that 18 months of Zyflamend supplementation was associated with a 41% decrease in PSA levels and a reduced rate of prostate cancer progression compared to historical controls. A separate open-label study in 23 patients with recurrent prostate cancer reported PSA stabilization in a subset of participants taking three capsules daily, though no control arm limits interpretation. Preclinical research using human prostate cancer cell lines (PC-3, LNCaP) demonstrated dose-dependent induction of apoptosis and inhibition of cell proliferation. Overall, the human evidence base remains limited to small pilot trials and observational data, warranting larger randomized controlled trials before definitive conclusions can be drawn.

Nutritional Profile

Zyflamend is a proprietary polyherbal blend (New Chapter) containing approximately 10 standardized herbal extracts per capsule (typically 2 capsules = 1 serving). Key components and approximate concentrations per serving: Holy Basil (Ocimum sanctum) extract ~160mg (standardized to ursolic acid, eugenol); Turmeric (Curcuma longa) rhizome extract ~160mg (standardized to ~95% curcuminoids including curcumin, bisdemethoxycurcumin, demethoxycurcumin); Ginger (Zingiber officinale) extract ~160mg (standardized to gingerols and shogaols); Green Tea (Camellia sinensis) leaf extract ~160mg (standardized to EGCG and catechins, ~45% polyphenols); Rosemary (Rosmarinus officinalis) extract ~160mg (standardized to rosmarinic acid and carnosol); Hu Zhang/Japanese Knotweed (Polygonum cuspidatum) extract ~80mg (standardized to resveratrol ~5%); Chinese Goldthread (Coptis chinensis) extract ~80mg (standardized to berberine); Barberry (Berberis vulgaris) extract ~80mg (standardized to berberine alkaloids); Oregano (Origanum vulgare) extract ~80mg (standardized to carvacrol and thymol); Baikal Skullcap (Scutellaria baicalensis) extract ~80mg (standardized to baicalin and baicalein). Macronutrients: negligible calories (~5 kcal/serving), minimal carbohydrates (<1g), minimal fat (<0.5g), minimal protein (<0.5g). Micronutrients: trace minerals from plant matrices. Bioactive compounds: curcuminoids, EGCG, gingerols, ursolic acid, rosmarinic acid, carnosol, berberine, resveratrol, baicalin, eugenol, carvacrol — all exhibiting NF-κB inhibitory, COX-2 inhibitory, and AMPK-activating properties. Bioavailability notes: curcuminoids have poor oral bioavailability (~1%) without piperine or lipid carriers; formulation uses supercritical CO2 extraction to enhance bioactive retention; resveratrol undergoes rapid hepatic conjugation limiting systemic exposure; berberine has moderate absorption (~5–20%) with P-glycoprotein efflux limiting intestinal uptake; EGCG bioavailability is moderate and dose-dependent; lipophilic compounds (carnosol, carvacrol) may benefit from dietary fat co-ingestion. Overall bioavailability of the blend is enhanced by the supercritical extraction process but remains variable across individual compounds.

Preparation & Dosage

Standard clinical dosage is 2 capsules per serving, delivering: rosemary 150mg, turmeric 110mg, ginger 100mg, holy basil 100mg, green tea 100mg, hu zhang 80mg, Chinese goldthread 40mg, barberry 40mg, oregano 40mg, and Chinese skullcap 20mg. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Omega-3 fatty acids, Boswellia serrata, Quercetin, Vitamin D3, Probiotics

Safety & Interactions

Zyflamend is generally well tolerated at the standard dose of two to three capsules daily, with the most commonly reported side effects being mild gastrointestinal upset, heartburn, and nausea, particularly when taken on an empty stomach. Because several constituent herbs—including turmeric, ginger, and holy basil—possess antiplatelet and anticoagulant properties, concurrent use with warfarin, clopidogrel, aspirin, or other blood-thinning agents may increase bleeding risk and should be supervised by a physician. Individuals with hormone-sensitive conditions should exercise caution, as rosemary and other components may weakly modulate estrogen pathways. Zyflamend has not been adequately studied in pregnant or breastfeeding women and should be avoided in these populations.